MICHAEL BRUCE GROSS
Medical Practice in Plymouth Meeting, PA
License number
Pennsylvania MD016231E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Plymouth Meeting, PA 19462
Professional information
Dr. Michael B Gross, Newark DE - MD (Doctor of Medicine)
Specialties:
Obstetrics & Gynecology
Address:
4755 Ogletown Stanton Rd, Newark 19718
(302) 733-1042 (Phone), (302) 733-3166 (Fax)
502 W Germantown Pike STE 750, Plymouth Meeting 19462
(302) 733-1042 (Phone), (302) 733-3166 (Fax)
502 W Germantown Pike STE 750, Plymouth Meeting 19462
Certifications:
Obstetrics & Gynecology, 1978
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Medicine And Dentistry of New Jersey / Newark
Graduated: 2011
Temple University Hospital
University of Medicine And Dentistry of New Jersey / Newark
Graduated: 2011
Temple University Hospital
Compositions And Methods For Using Same For Improving The Quality Of The Meibum Composition Of Meibomiam Glands
US Patent:
2014002, Jan 23, 2014
Filed:
Mar 12, 2013
Appl. No.:
13/815599
Inventors:
S. Gregory Smith - Yorklyn DE, US
Michael B. Gross - Plymouth Meeting PA, US
Olav E. Sandnes - Mt. Bethel PA, US
Michael B. Gross - Plymouth Meeting PA, US
Olav E. Sandnes - Mt. Bethel PA, US
International Classification:
A61K 31/202, A61K 31/593, A61K 31/232
US Classification:
514167, 514560, 514547
Abstract:
This invention relates to methods for improving changing the quality of the meibum composition of the meibomian glands to enhance or improve the lipid layer of the tear and increase tear breakup time by way of elevating the omega-3 index in patients suffering from symptoms of dry eye, posterior blepharitis, and/or meibomian gland dysfunction. The methods comprise administering a supplementation of omega-3 fatty acids to a patient having an inflamed meibomian gland so as to facilitate an increase in the amount of omega-3's acting as an anti-inflammatory and, respectively, decrease the amount of omega-6′s (arachidonic acid) acting as an inflammatory in the composition of the meibum, thereby normalizing the lipid layer of the tear and effectively reducing the associated symptoms. In certain embodiments, the supplementation of omega-3's comprises the esterified or re-esterified triglyceride form.
Compositions And Methods For Using Same For Treating Posterior Blepharitis
US Patent:
2013006, Mar 14, 2013
Filed:
Jul 18, 2012
Appl. No.:
13/507673
Inventors:
S. Gregory Smith - Yorklyn, DE
Michael B. Gross - Plymouth Meeting PA, US
Olav E. Sandnes - Mt. Bethel PA, US
Michael B. Gross - Plymouth Meeting PA, US
Olav E. Sandnes - Mt. Bethel PA, US
International Classification:
A61K 31/59, C07C 69/587, A61K 31/593, A61K 31/202
US Classification:
514167, 554224
Abstract:
This invention relates to methods for administering an effective amount of a dietary or nutritional supplement composition that effectively changes the quality of the meibum lipid composition of inflamed or dysfunctional meibomian glands so as to improve or increase tear break up time, reduce tear osmolarity, and elevate the omega-3 index, while reducing or eliminating the symptoms associated with dry eye or meibomianitis. The dietary or nutritional supplement composition administered to the patient suffering from inflamed or dysfunctional meibomian glands comprises an effective amount of omega-3 fatty acids.